Baby Giants Investing

#46 - Robot replacements, Unprofitable buybacks, Objective Corp, Genetic Signatures, & Catapult

September 22, 2022 BabyGiants Episode 46

Andrew, Matt and Claude, chat through some positive developments in AI and immunology, Charter Hall CEO David Harrison's controversial claim, Russia's conscription, and we answer your questions (oOh!Media, Objective Corporation, Pro Medicus, Genetic Signatures), and Catapult Group International. 


Follow us on Twitter: @BabyGiantsPod

-----

1:04 - Good News: AI

3:51 - Good News: Immunology and lupus

4:43 - Charter Hall (ASX: CHC) CEO's controversial claim

12:30 - Biden says U.S. would defend Taiwan

14:38 - Russia's conscription

16:02 - oOh!Media's (ASX: OML) buyback

24:01 - Objective Corporation (ASX: OCL) (1)

30:33 - Pro Medicus (ASX: PME)

32:02 - Objective Corporation (ASX: OCL) (2)

39:27 - Genetic Signatures (ASX: GSS)

41:42 - Catapult Group International (ASX: CAT)